Bellevue Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
FP
HCM
PCMC
WCG
Bellevue Group's CELG Position: Q4 2019 in Review
Bellevue Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,085,600 shares — an estimated $108M sold.
Bellevue Group first reported a position in CELG in Q1 2016 and held it in 15 quarters. The position peaked at $171M in Q2 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Bellevue Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Bellevue Group sold 1,085,600 Celgene Corp shares in Q4 2019, an estimated $108M.
- Bellevue Group first reported a position in Celgene Corp in Q1 2016 and held it in 15 quarters.
- Bellevue Group's Celgene Corp position peaked at $171M in Q2 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Bellevue Group's 13F filing for Q4 2019, filed 14 Feb 2020.